Dorsal Root Ganglion Stimulation for the Treatment of Chronic Neuropathic Knee Pain.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
11 2020
Historique:
received: 08 06 2020
revised: 15 07 2020
accepted: 17 07 2020
pubmed: 28 7 2020
medline: 14 5 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

To elucidate the efficacy of dorsal root ganglion stimulation in the treatment of chronic neuropathic pain confined to the knee. Retrospective analysis of prospectively collected data of 14 consecutive patients undergoing dorsal root ganglion stimulation for chronic knee pain, in a single center. The primary outcome measure was pain reduction assessed by numeric pain rating scale score preoperatively and postoperatively. Secondary outcomes included quantification of percentage of pain area covered by stimulation, and reduction in usage of opioid medications. Responders were defined as patients that experienced a greater than or equal to 50% improvement in their preoperative pain score. Fourteen patients were implanted with dorsal root ganglion stimulator electrodes; 8 had a single L3 lead implanted, 1 patient had a single L4 lead implanted, and 3 patients had 2 leads implanted (L3 and L4). Two patients had their leads explanted: 1 for non-efficacy, and 1 for repeated electrode displacement. The most common indication for surgery was type 2 complex regional pain syndrome, secondary to either trauma or postoperative chronic pain (either knee replacement or arthroscopy). Median preoperative numeric rating scale score was 8.5, median postoperative numeric rating scale score was 2 (P = 0.002, Wilcoxon signed rank test). The median improvement in pain score was 80%. All 12 patients undergoing chronic stimulation were responders. Median coverage of pain area was 85%. All but 1 patient who was on opioid medication prior to surgery had reduced the dosage of regular opioid. In selected patients, dorsal root ganglion stimulation is an extremely efficacious means of treating otherwise refractory chronic knee pain.

Sections du résumé

BACKGROUND
To elucidate the efficacy of dorsal root ganglion stimulation in the treatment of chronic neuropathic pain confined to the knee.
METHODS
Retrospective analysis of prospectively collected data of 14 consecutive patients undergoing dorsal root ganglion stimulation for chronic knee pain, in a single center. The primary outcome measure was pain reduction assessed by numeric pain rating scale score preoperatively and postoperatively. Secondary outcomes included quantification of percentage of pain area covered by stimulation, and reduction in usage of opioid medications. Responders were defined as patients that experienced a greater than or equal to 50% improvement in their preoperative pain score.
RESULTS
Fourteen patients were implanted with dorsal root ganglion stimulator electrodes; 8 had a single L3 lead implanted, 1 patient had a single L4 lead implanted, and 3 patients had 2 leads implanted (L3 and L4). Two patients had their leads explanted: 1 for non-efficacy, and 1 for repeated electrode displacement. The most common indication for surgery was type 2 complex regional pain syndrome, secondary to either trauma or postoperative chronic pain (either knee replacement or arthroscopy). Median preoperative numeric rating scale score was 8.5, median postoperative numeric rating scale score was 2 (P = 0.002, Wilcoxon signed rank test). The median improvement in pain score was 80%. All 12 patients undergoing chronic stimulation were responders. Median coverage of pain area was 85%. All but 1 patient who was on opioid medication prior to surgery had reduced the dosage of regular opioid.
CONCLUSIONS
In selected patients, dorsal root ganglion stimulation is an extremely efficacious means of treating otherwise refractory chronic knee pain.

Identifiants

pubmed: 32711140
pii: S1878-8750(20)31623-5
doi: 10.1016/j.wneu.2020.07.102
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e303-e308

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Sean C Martin (SC)

Department of Neurological Surgery, Oxford University Hospitals, Oxford, UK; Nuffield Department of Surgical Science, University of Oxford, Oxford, UK. Electronic address: sean.martin@nds.ox.ac.uk.

Alistair R Macey (AR)

Department of Trauma and Orthopaedics, Queen Elizabeth University Hospital, Glasgow, UK.

Ashley Raghu (A)

Nuffield Department of Surgical Science, University of Oxford, Oxford, UK.

Tamara Edwards (T)

Department of Neurological Surgery, Oxford University Hospitals, Oxford, UK.

Clare Watson (C)

Department of Neurological Surgery, Oxford University Hospitals, Oxford, UK.

Stana Bojanić (S)

Department of Neurological Surgery, Oxford University Hospitals, Oxford, UK.

James J FitzGerald (JJ)

Department of Neurological Surgery, Oxford University Hospitals, Oxford, UK; Nuffield Department of Surgical Science, University of Oxford, Oxford, UK.

Alexander L Green (AL)

Department of Neurological Surgery, Oxford University Hospitals, Oxford, UK; Nuffield Department of Surgical Science, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH